April 17, 2024 Sleep Apnea Reduced in People Who Took Zepbound, Eli Lilly Reports This post was originally published on this siteThe company reported results of clinical trials involving Zepbound, an obesity drug in the same class as Novo Nordisk’s Wegovy.